Similar Papers

Paper Title
Journal
Date
Author
Analysis of reasons for Emergency Department (ED) visits and subsequent hospital admissions in patients with solid malignancies: A retrospective study from a cancer center in rural Maine.
Anannya Patwari ... Abigail Hatch
Journal of Clinical Oncology | VOL. 39
Anannya Patwari, et. al.Anannya Patwari ... Abigail Hatch
01 Oct 2021
Analysis of reasons for emergency department (ED) visits and resulting hospital admissions in breast cancer patients: A retrospective study from rural cancer center in Maine.
Anannya Patwari ... Courtnery Brann
Journal of Clinical Oncology | VOL. 39
Anannya Patwari, et. al.Anannya Patwari ... Courtnery Brann
20 May 2021
Case report: Post-therapeutic laryngeal carcinoma patient possessing a high ratio of aneuploid CTECs to CTCs rapidly developed de novo malignancy in pancreas.
Jiaoping Mi ... Fang Yang
Frontiers in oncology | VOL. 12
Jiaoping Mi, et. al.Jiaoping Mi ... Fang Yang
12 Sep 2022
High frequency and allele‐specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus
Nv Bogdanova ... T Dörk
Clinical Genetics | VOL. 78
Nv Bogdanova, et. al.Nv Bogdanova ... T Dörk
06 Sep 2010
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
Updated results from the phase Ib/II study of fruquintinib combined with SOX and toripalimab in patients with advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC).
Xiangrui Meng ... Lulu Guan
Journal of Clinical Oncology | VOL. 43
Xiangrui Meng, et. al.Xiangrui Meng ... Lulu Guan
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.